Aurigene Discovery Technologies (M) Sdn Bhd
W.P Kuala Lumpur
Contract Manufacturing Organisation
Aurigene Discovery Technologies (M) Sdn Bhd is a wholly owned subsidiary of Aurigene Discovery Limited, India. It is a therapeutic drug discovery biotech company involved in small molecule and peptide drug discovery. Aurigene’s key businesses entail collaborative drug discovery partnerships, licensing and drug discovery services. Based in Bangalore , Hyderabad and Kuala Lumpur, Aurigene has a fully integrated drug discovery infrastructure from Hit Generation to pre-clinical development. Aurigene has partnered with six of the top ten pharma companies including Novartis, Sanofi, Amgen Merck Serono and many other US and Europian mid pharma companies. Aurigene developed compounds are in various stages of preclinical and clinical development. The company’s therapeutic areas of focus include Oncology, Inflammation (OA, RA), Metabolic Disorders and infectious diseases.
At Aurigene Malaysia, we offer contract research services that help pharmaceutical and biotech companies in their R & D success. Our integrated offering allows our clients to access multiple outsourcing choices across the drug discovery and development processes covering: Medicinal chemistry; Structural Biology; In-vitro screening; In-vivo biology; IND support; Formulation development; Scale-up support, etc (see company brochure attachment 1).